FPA Patent Attorneys has added to its growing practice with the appointment of Senior Associate Danny Gelman to its chemistry and biotechnology team.
Danny has commenced at our Melbourne office after previously working for another leading Australian intellectual property firm.
Danny specialises in the drafting and prosecution of global patent families across the chemical field including organic synthetic chemistry, medicinal chemistry and materials chemistry, pharmaceuticals, plant-based extracts, agribusiness, biotechnology, and food and beverage. He is a registered Australian and New Zealand patent attorney.
FPA Patent Attorneys Managing Principal James Cherry said that Danny’s appointment was another step in further strengthening the firm’s expertise in the chemistry and biotechnology sectors.
“We are delighted to have Danny join us and add his experience to what is already a market-leading and award winning team” said James.
Tom Gumley, Principal from the Chemistry and Biotechnology team at FPA said “Our clients will benefit from Danny’s combined experience in academia, the pharmaceutical industry and as a patent attorney. He has a deep understanding of the path from conception of an invention through to commercialisation.”
Danny completed his Bachelor Science (First Class Honours) at Monash University before completing his PhD at Monash University focussing on organic synthetic chemistry.
During his PhD studies, Danny was awarded a Fulbright Scholarship and spent a year as a visiting scientist at Harvard University. In 2009 and 2010, Danny worked in the UK pharmaceutical industry as a senior scientist in a drug discovery role. While in the UK, Danny also completed a course in technology-based entrepreneurship at the Saïd Business School at Oxford University.
The commencement of Danny follows the recent appointment of Patent Attorney Ben Hayes, Patent Scientists Sinth Jegaskanda and Rohan Williams, Patent Engineer Alison Jackson and the elevation of two attorneys to Senior Associate – Akanksha Dahiya and Alister McCowan.